On the banks of the Monongahela, where generations of Pittsburgh workers once poured steel, a different kind of manufacturing is taking shape. The University of Pittsburgh's Pitt BioForge facility at Hazelwood Green is now in its final construction phase, set to open this fall as one of the most ambitious biomanufacturing centers in the country. And before the doors have even opened, the university has already put its first class of neighborhood residents on a path to careers inside those walls.
In April, the inaugural cohort of the Life Sciences Bridge Program graduated. The 50-hour paid workforce initiative was designed specifically for Greater Hazelwood residents without college degrees, introducing participants to careers in biotechnology and life sciences while connecting them with additional educational pathways and employment opportunities at BioForge and partner companies. It was built, in part, from a simple question Pitt asked residents when BioForge was first announced: how do we make sure that the innovation happening on this street actually opens doors for the people who live on the next street over?
The results of that community-first approach were on display at a late April gathering hosted in the restored Roundhouse at Hazelwood Green — the former locomotive maintenance building from the old J&L Steel complex, now transformed into a modern coworking and event space. At a Pitt Alumni Association speaker series event there, Heidi Ward, director of Pitt's Greater Hazelwood Neighborhood Commitment, Ian Johnson, director of life sciences at BioForge, and professor Rosta Farzan of Pitt's School of Computing and Information Sciences outlined what the neighborhood's next chapter looks like from both inside and outside the research complex.
"This building is a metaphor for what's possible when research, industry, and neighborhood partnerships all work together to shape Pittsburgh's next chapter."
Heidi Ward, Director, Pitt Greater Hazelwood Neighborhood Commitment
Johnson, a Pittsburgh native and Pitt alumnus, described BioForge's core mission in direct terms: the facility takes "really cool science" and makes it manufacturable, so it can impact people immediately. BioForge will focus on gene and cell therapies targeting conditions including cancer, neurological disease, and blindness. Among the projects in development is "Furnace," an mRNA brokerage platform built on lessons from the COVID-19 pandemic, alongside microneedle patch technology developed by Pitt-connected researchers. One startup, Panther Life Sciences, has already relocated its operations to Pittsburgh after working with BioForge's team — a signal of the facility's magnetic effect on the regional life sciences ecosystem.
A Community Asset, Not Just a Research Facility
What sets this story apart is the deliberate effort to tie BioForge's fortunes to those of the Greater Hazelwood neighborhood surrounding it. Pitt has been engaged in the community for more than 25 years, but the scale of BioForge prompted a deeper reckoning. When the university surveyed residents, it heard the same concern repeatedly: people were unfamiliar with the life sciences field and hesitant to commit months to training they weren't sure would lead somewhere. The Bridge Program was designed to close that gap — and it is working.
Farzan's research adds another dimension, bringing community members into the design of tools and systems being developed around them. One initiative centered on neighborhood air quality monitoring, with local residents helping identify sensor placement locations and students participating in data collection and public education. The approach reflects a broader principle: that successful institutional partnerships require patience, consistency, and trust — particularly in neighborhoods with a long memory of promises made and not kept by large institutions.
For Pittsburgh, BioForge represents something genuinely new: an economic anchor that is both globally competitive and explicitly designed to share its gains with the neighborhood it inhabits. The region that built the infrastructure of American industry is now building the infrastructure of precision medicine — and this time, the people living in the shadow of the facility are being invited inside before the lights come on.